In brief On 13 February 2026, the Health Sciences Authority (HSA) published the findings of its public consultation on the proposed exemption from manufacturer’s licensing and product registration requirements for artificial intelligence software as a medical device (AI-SaMD) developed by selected public healthcare entities for use in public healthcare (AI‑SaMD…
Government advances sector‑based AI regulation as public consultation nears In brief South Africa’s Draft National AI Policy has…
In brief In depth Companion models are a primary focus of recent litigation and lawmaking Although the first…
CEO fraud is evolving with artificial intelligence, shifting from mass phishing to highly targeted attacks that are harder to detect. Deepfake technology and hyper-realistic scenarios demand stronger compliance programs, ISO 37003-based fraud control systems, and proactive protocols to protect organizations against this rising threat.